# OU Health account plan

> OU Health is Oklahoma's nonprofit academic health system, with hospitals, physicians and pharmacy; revenue projected at $3.6 billion for FY2026.

## At a glance

OU Medicine, Inc., doing business as OU Health, is Oklahoma's nonprofit integrated academic health system: three acute care hospitals, The Children's Hospital (subleased from the University Hospitals Trust), a retail specialty pharmacy business, a reference laboratory, medical office buildings and the faculty physician enterprise OU Health Partners. Its sole member is the University Hospitals Trust, a public trust of the state of Oklahoma, and it funds research and medical education at the University of Oklahoma. In FY2025 (year ended June 30, 2025) total revenues were $3,215,846 thousand, up from $2,754,537 thousand, with operating income of $165,663 thousand. The board expects revenue to reach a projected $3.6 billion by June 30, 2026.

## Business units

- **Hospitals and other** (about 73% of FY2025 total revenue ($2,345,969 thousand of patient service revenue)): Three acute care hospitals, The Children's Hospital, the reference laboratory and medical office buildings, including the Level 1 trauma program and graduate medical education funded through Oklahoma subsidy payments.
- **Physician group - OU Health Partners** (about 10% of FY2025 total revenue ($332,989 thousand of patient service revenue)): The exclusive physician enterprise and medical practice of the University of Oklahoma faculty physicians, formed in the 2021 integration and controlled by OU Health.
- **Pharmacy** (about 15% of FY2025 total revenue (pharmacy revenues approximated $489 million)): Retail specialty pharmacy and contract pharmacy business priced on contracted rates with pharmacy benefit managers; revenue rose from $375 million in FY2024.
- **OUMI Ventures**: 85% owned venture that builds freestanding emergency rooms and urgent care facilities across the Oklahoma City metropolitan area and central Oklahoma.
- **Academic Partners Insurance Company (APIC)**: Vermont-licensed captive insurer covering medical professional and general liability for OU Health and its medical professionals, consolidated from July 1, 2024.

## Strategic priorities

- **Continued accelerated growth**: Revenue grew organically from $1.9 billion in June 2022 to a projected $3.6 billion by June 30, 2026, and the board says its focus on continued accelerated growth is unwavering under the new CEO.
- **Physician recruitment and complex care**: A net 162 new physician positions were recruited to position OU Health as a destination medical center for the most complex care.
- **Pediatric heart and behavioral health**: Just over a $200 million investment in the Pediatric Heart Program with state officials and philanthropic partners, plus investment in pediatric behavioral health.
- **Cancer care expansion**: Stephenson Cancer Center, the state's only National Cancer Institute-designated Cancer Center, added locations in Norman, Tulsa and McAlester and now treats 1 in 4 Oklahomans with cancer.
- **Ambulatory and emergency access**: Ambulatory services grew 51%, trending toward over 1 million visits in fiscal year 2026, and emergency volume rose 24% from 104,861.
- **Quality and pay for performance**: Infection rates moved from the bottom 10% to the top 10% nationally, and the first organisation-wide pay-for-performance program invested $22 million in 2025.

## Latest results

In FY2025 (year ended June 30, 2025) total revenues rose to $3,215,846 thousand from $2,754,537 thousand, with patient service revenue of $2,678,958 thousand and pharmacy revenues of about $489 million. Operating income rose to $165,663 thousand from $76,832 thousand, and the excess of revenues over expenses to $116,409 thousand from $54,999 thousand. Cash and cash equivalents rose to $590,415 thousand. The board projects revenue of $3.6 billion by June 30, 2026.

## Investments and deals

- **Oncology acquisition**: OU Health bought an oncology business for $13 million in June 2025.
- **Pediatric Heart Program**: Just over a $200 million investment, made in partnership with state officials and philanthropic partners.
- **Capital spending**: Purchases of property and equipment were $84,740 thousand in FY2025 vs $59,837 thousand, and construction in progress rose to $60,832 thousand.
- **Academic mission support**: Mission support to OU and OUHSC rose to $66 million from $31 million, plus $152 million of expenses under academic agreements.
- **Freestanding ERs and urgent care**: OUMI Ventures builds freestanding emergency rooms and urgent care facilities around Oklahoma City, with the Trust contributing approximately $15 million.

## Challenges and risks

- **Dependence on government payors**: Oklahoma subsidy payments of $650 million, Medicare of $498,085 thousand and Medicaid of $409,648 thousand; subsidies are partly repayable if Medicaid utilization, quality or uncompensated-care thresholds are missed.
- **Rising supply costs**: Supplies rose to $910,796 thousand from $720,593 thousand, and with salaries and benefits of $1,281,818 thousand are the largest spend categories.
- **Federal awards compliance**: The single audit found two material weaknesses on a federal program of $1,496,182: no documented procurement procedures and late or missing federal reports.
- **Debt load**: Long-term debt was $1,488,951 thousand, mostly health system revenue bonds, with $214,764 thousand due in FY2029.
- **Malpractice and regulation**: A self-insurance accrual of approximately $97 million for malpractice, and exposure to licensure, accreditation and fraud and abuse rules.

## What leadership says

> "our focus on continued accelerated growth is unwavering" — G. Rainey Williams Jr., Chair, OU Health Board of Directors, Message on the CEO succession, February 16, 2026

> "from $1.9 billion in revenue in June 2022 to a projected $3.6 billion by June 30, 2026, representing nearly 90% growth in just four years." — G. Rainey Williams Jr., Chair, OU Health Board of Directors, Message on the CEO succession, February 16, 2026


## Where a supplier can help

- **Procurement and grants compliance**: Tied to the federal awards material weaknesses: procurement policy, suspension-and-debarment screening and grant reporting tools.
- **Supply chain and pharmacy cost control**: Tied to rising supply costs and pharmacy growth: purchasing, inventory and specialty pharmacy services.
- **Oncology and pediatric program build-out**: Tied to the cancer care expansion and the Pediatric Heart Program: medical equipment, clinical IT and facility suppliers.
- **Physician recruitment and workforce**: Tied to the net 162 new physician positions and the pay-for-performance program: recruiting, credentialing and performance management tools.
- **Ambulatory and ER site development**: Tied to ambulatory growth and OUMI Ventures: construction, equipment and patient access technology for new outpatient and emergency sites.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [OU Medicine, Inc. (OU Health) Consolidated Financial Statements, years ended June 30, 2025 and 2024, with single audit reports](https://app.fac.gov/dissemination/report/pdf/2025-06-GSAFAC-0000412955)

Annual report · 2025-11-17

- OU Medicine, Inc., doing business as OU Health, is Oklahoma's nonprofit integrated academic health system: three acute care hospitals, The Children's Hospital (subleased from the University Hospitals Trust), a retail specialty pharmacy business, a reference laboratory, medical office buildings, and the faculty physician enterprise OU Health Partners, Inc.
- FY2025 (year ended June 30, 2025): total revenues $3,215,846 thousand vs $2,754,537 thousand in FY2024; patient service revenue $2,678,958 thousand; operating income $165,663 thousand (FY2024: $76,832 thousand); excess of revenues over expenses $116,409 thousand.
- Revenue mix by service line: Hospitals and other $2,345,969 thousand and Physician group $332,989 thousand of patient service revenue; pharmacy revenues approximated $489 million (reported in other revenue).
- Payor mix is government-heavy: Oklahoma subsidy payments $650 million (Level 1 trauma, graduate medical education, state trauma fund and the SoonerSelect Medicaid managed care program), Medicare $498,085 thousand, Medicaid $409,648 thousand, managed care and other $1,093,451 thousand.
- Cost base: salaries and benefits $1,281,818 thousand and supplies $910,796 thousand (up from $720,593 thousand), other operating $678,005 thousand; supplies and staffing are the largest spend categories.
- Balance sheet: cash and cash equivalents $590,415 thousand (up from $405,466 thousand), long-term debt $1,488,951 thousand (mostly Series 2018B/2018C and 2022A health system revenue bonds), lines of credit totaling $140 million undrawn.
- Growth moves: consolidated the captive insurer Academic Partners Insurance Company (APIC) from July 1, 2024; acquired an oncology business for $13 million in June 2025; OUMI Ventures (85% owned) builds freestanding emergency rooms and urgent care facilities around Oklahoma City.
- Academic mission: mission support to OU and OUHSC rose to $66 million (FY2024: $31 million), plus $152 million of expenses under academic agreements in operating costs; capital spending on property and equipment was $84,740 thousand.
- Risks flagged: reliance on Medicare, Medicaid and state subsidy programs (subsidy repayable if Medicaid utilization, quality or uncompensated-care thresholds are missed), regulatory compliance, malpractice claims; the federal-award audit found two material weaknesses (procurement, grant reporting) on a federal program of $1,496,182.

### [A Message from OU Health Board Chair G. Rainey Williams Jr. on the CEO succession](https://ou.edu/content/dam/president/documents/messages-and-statements/ou-health-board-chair-memo.pdf)

Executive talk · G. Rainey Williams Jr., Chair, OU Health Board of Directors · 2026-02-16

- Board chair G. Rainey Williams Jr. announced that inaugural president and CEO Dr. Richard P. Lofgren retires effective June 30, 2026 and that COO Jonathan Curtright becomes president and CEO on July 1, 2026.
- Curtright was recruited by Lofgren in August 2022 as chief operating officer and "co-architect of OU Health's transformation".
- Revenue grew organically from $1.9 billion in June 2022 to a projected $3.6 billion by June 30, 2026, "nearly 90% growth in just four years".
- S&P Global Ratings and Moody's Ratings both raised OU Health's bond ratings twice over the past two years.
- Growth levers: a net 162 new physician positions recruited, just over a $200 million pediatric heart investment, Stephenson Cancer Center expanded to Norman, Tulsa and McAlester and now treating 1 in 4 Oklahomans with cancer.
- Volumes: admissions up 22.3% over four years, ambulatory services up 51% (trending toward over 1 million visits in FY2026), emergency visits up 24% from 104,861.
- Quality and people: infection rates moved from the bottom 10% to the top 10% nationally; first organisation-wide pay-for-performance program, investing $22 million in 2025.
- The board's message for the next CEO: "continued accelerated growth" under the executive team Lofgren built.

## Questions about OU Health

### What is OU Health?

OU Health is Oklahoma's nonprofit integrated academic health system, with three acute care hospitals, The Children's Hospital, a specialty pharmacy business, a reference laboratory and the OU Health Partners faculty physician group.

### What is OU Health's revenue?

Total revenues were $3,215,846 thousand in FY2025 (year ended June 30, 2025), and the board projects $3.6 billion by June 30, 2026.

### What is OU Health's strategy?

Continued accelerated growth through physician recruitment, subspecialty care such as pediatric heart and cancer, ambulatory expansion and performance-based management.

### Who leads OU Health?

Jonathan Curtright became president and CEO on July 1, 2026, succeeding Dr. Richard P. Lofgren; G. Rainey Williams Jr. chairs the board.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
